Skip to content

Responsibility in Drug Advertising Act of 2025

In committee: it can still change before the session ends.

US S 483 · Senate Bill · 119th Congress

Stage
In committee
Started in
Senate
Sponsors
3
Latest action
Feb 6, 2025

What it does

This bill prohibits direct-to-consumer advertising of new drugs during the first three years following their approval by the Food and Drug Administration (FDA). Direct-to-consumer advertising includes advertising via social media.

Official summary · Introduced in Senate · Feb 6, 2025

Titles and provisions can change as the bill moves.

Read the full textRead it on the official site

Where it stands

  1. Introduced (Done)

    Feb 6, 2025

  2. Committee (Current step)

    In committee · Feb 6, 2025

  3. Floor (Not started)

  4. Law (Not started)

What moved

Loading recorded actions…

Who is involved

Sponsors

The lawmakers who put their names on it, lead sponsors first.

In the news

Reporting that may mention this subject. Possible matches are labeled.

Loading coverage…

Where it goes next

While a bill can still move, the questions are about people and money.

Work with this bill

Responsibility in Drug Advertising Act of 2025 | 52